VIENNA, April 12, 2022 /PRNewswire/ --Inviting someone for a coffee or smiling at a stranger could inspire thousands more acts of kindness, according to Julius Meinl – one of Europe's oldest coffee brands. Julius Meinl fuels meaningful moments with ‘Say Thank You’ initiative To mark its 160th anniversary, Julius Meinl is lifting the lid on simple acts of gratitude with a new study into everyday moments that mean the most. 4,000 adults were polled, with responses highlighti

YICHANG, China, April 11, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "the Company", 600298.SH), a listed global yeast and yeast extract manufacturer, is opening a new factory of food ingredients. The factory – loaded with state-of-the-art facilities that enable automated operation and heightened quality control – offers enhanced productivity, and higher energy efficiency, with the first batch of products having rolled off its smart mixed production line.

DUBLIN, April 11, 2022 /PRNewswire/ -- EnigmaSoft Limited's SpyHunter 5 includes the HelpDesk – a one-on-one personalized technical support service. Sometimes users encounter unique problems related to stubborn malware infections that traditional anti-malware software may not fully detect or remove. SpyHunter 5's HelpDesk connects users directly to our SpyHunter 5 technicians who can create custom malware fixes to address unique malware issues where needed. SpyHunter 5's HelpDesk is

We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers should disregard the news release, "Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative", issued 11-Apr-2022 over PR Newswire.

DAEJEON, South Korea, April 11, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company presented an updated preclinical data PMC-309, the Company's anti-VISTA antibody candidate at AACR (American Association for Cancer Research) 2022 Annual Meeting currently taking place both online and offline in New Orleans. PMC-309, one of the company's first

HONG KONG and SHANGHAI, April 11, 2022 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEx:2318; SSE:601318) has published its 2021 Sustainability Report. The sustainability report, the 13th from Ping An, highlights the Group's achievements in sustainability strategy, management, and operations as well as its milestones in environmental, social and governance performance. Advancing green fi

Designed in partnership with group of world-renowned artists, "NFTickets" will give access to a business class seat on a Miami-bound flight this November MIAMI, April 11, 2022 /PRNewswire/ -- TravelX, the company building the travel industry's first blockchain-based distribution protocol, today announced that it has joined forces with Air Europa, the third-largest Spanish airline flying to over 60 destinations around the world, to release the world's first NFT (non-fungible toke

Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas MOUNTAIN VIEW, Calif., April 11, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it closed an oversubscribed fundraising round to support the next stage of its development. Inves

BOSTON, April 11, 2022 /PRNewswire/ -- APRINOIA Therapeutics announces today that the U.S. Food and Drug Administration (FDA) has granted a may proceed authorization for its novel therapeutic anti-tau monoclonal antibody, APNmAb005, allowing the company to test and evaluate its safety in healthy subjects in a phase 1 single ascending dose study. APNmAb005 is a unique antibody that recognizes a conformation-dependent epitope present only in pathological forms of tau proteins. It preferentially

Making its debut on the fourth annual Financial Times ranking of 500 of Asia-Pacific's high-growth companies, INEX Innovate - the pioneering healthcare technology company targeting women's health - is one of only 20 healthcare companies listed in the prestigious line up. SINGAPORE, April 11, 2022 /PRNewswire/ -- Emerging from the National University of Singapore (NUS), INEX Innovate is a Singapore-based molecular diagnostics developer and medical laboratory operator.   

SPRING, Texas, April 11, 2022 /PRNewswire/ -- ExxonMobil introduced today its new Exceed™ S performance polyethylene (PE) resins, which deliver industry-leading combinations of stiffness and toughness while being easy to process.  Utilizing the company's latest innovations in polymer science, the new PE platform provides opportunities to reduce the complexity of film formulations and designs while improving film performance, conversion efficiency, and packaging durability versus current m

East Asia Pacific to reinvent, refresh and open new stores at more than 100 locations SINGAPORE, April 11, 2022 /PRNewswire/ -- Levi Strauss & Co. (NYSE: LEVI) today announced ambitious plans to accelerate sustainable business growth and drive commercial success in the East Asia Pacific (EAP) region. Central to the growth strategy is the diversification of the business across geographies, apparel categories and distribution channels. Levi Strauss & Co. will be launching new s

Next-generation inhaler will use Honeywell's Solstice® Air to reduce greenhouse gas emissions of propellant by up to 99.9 percent vs current inhaler propellant Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products  CHARLOTTE, N.C., April 11, 2022 /PRNewswire/ -- Honeywell (Nasdaq: HON) announced a commercial partnership with AstraZeneca (LON: AZN) to develop and bring to mark

The company will present the preclinical data of five novel drug candidates at AACR 2022 (on April 8-13). Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, April 11, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer, today announced the publication

Offering a faster and more cost-effective way for businesses to send and receive global payments SINGAPORE, April 11, 2022 /PRNewswire/ -- Tranglo Pte Ltd has launched a comprehensive business payment solution that helps businesses send and receive global payments quickly. Tranglo Business is a comprehensive payment solution for corporates of all sizes. Tranglo Business is developed exclusively for corporates of all sizes, specifically non-payment providers such as e-

From Jabbawockeez to Simon Sinek, the UNBrokerage Brings Down the House, Proving 'Anything is Possible' Pledging to Fulfill Even More Dreams in 2022 LAS VEGAS, April 9, 2022 /PRNewswire/ -- During its largest event ever, Realty ONE Group International, a modern, purpose-driven lifestyle brand and ONE of the fastest growing franchisors in the world, rocked the Aria Resort & Casino in Las Vegas, NV, this week during its 2022 ONE SUMMIT, drawing impassioned real estate professionals and fr

- Part of global promotion campaign of K-spicy to commemorate the 10th anniversary of the launching Buldak SEOUL, South Korea, April 9, 2022 /PRNewswire/ -- Samyang Foods announced on April 8 that it will participate as the main sponsor of BTS PERMISSION TO DANCE ON STAGE – LAS VEGAS, commemorating the 10th anniversary of the launching Buldak, Korean noodles with secret spicy sauce. Samyang Foods’ Buldak Brand participates as the main sponsor of BTS PERMISSION TO DANCE ON STAGE – LAS VEG

BEIJING, April 8, 2022 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that they have reached an agreement with BeiGene (Beijing) Co., Ltd. ("BeiGene") (NASDAQ code: BGNE; Hong Kong Stock Exchange code: 06160; Shanghai Stock Exchange code: 688235) on March 10, for licensing of Biocytogen's fully human antibody RenMab™/RenLite™ mice platform with proprietary intellectual property rights of Biocytogen to develop fully human monoclonal antibodies, bispecific

Identified knockdown of target genes for the NASH treatment candidate Reduction of ALT and AST liver marker levels observed in monkey models Company to present results at the 2022 Academic Symposium of the Korean Endocrine Society SUWON, South Korea, April 8, 2022 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the Company has identified effective inhibition of target gene expression in a non-clinical monk

BEIJING, April 8, 2022 /PRNewswire/ -- The first episode of a series of peony-themed live streaming activities kicked off on Wednesday in Luoyang city, central China's Henan Province, bringing the audience a unique online journey of the city's peony culture and industry. Photo shows the Longmen Grottoes surrounded with peony flowers in Luoyang, central China's Henan Province. The one-hour program started with a three-minute video showcasing the history and charm of Luoyang, after whic